Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study

November 2025 in “Journal of Investigative Dermatology”

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A Phase IIA Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Selective Androgen Receptor Modulator (SARM), MK-0773 in Female Participants with Sarcopenia

research A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

211 citations , May 2013 in “Journal of Nutrition Health & Aging”

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

research 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia

November 2020 in “Journal of The American Academy of Dermatology”

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

research Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer

2 citations , December 2013 in “Cancer research”

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

research S-l Combined with Paclitaxel as Second-line Chemotherapy for Advanced Gastric Cancer

January 2012 in “Zhongguo quanke yixue”

The treatment was effective and tolerable for advanced gastric cancer.

research [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].

3 citations , April 2020 in “PubMed”

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

research High Response Rate to Bexxar in Advanced Stage Prior Treatment-Resistant Follicular Lymphoma

2 citations , March 2005 in “Cancer biology & therapy”

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

research A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata

5 citations , February 2025 in “Pediatric Dermatology”

Ritlecitinib was generally well tolerated in children with alopecia areata.

research 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers

July 2024 in “Journal of Investigative Dermatology”

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

research 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia

1 citations , November 2022 in “Journal of Investigative Dermatology”

ALRN-6924 may prevent hair loss caused by chemotherapy.

← Previous page